Viewing Study NCT01659151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-03 @ 6:56 AM
Study NCT ID: NCT01659151
Status: COMPLETED
Last Update Posted: 2025-11-04
First Post: 2012-08-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None melanoma View
None cell transfer View
None ACT View
None T-cell View
None immunotherapy View
None antibodies View
None lymphocytes View